Durvalumab (D) +- tremelimumab (T) + platinum-etoposide (EP) in extensive-stage small-cell lung cancer (ES-SCLC): RNA sequencing analysis to explore canonical markers of IO activity in CASPIAN
Durvalumab;Etoposide;Tremelimumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Durvalumab (D) +- tremelimumab (T) + platinum-etoposide (EP) in extensive-stage small-cell lung cancer (ES-SCLC): RNA sequencing analysis to explore canonical markers of IO activity in CASPIAN ### Output: Durvalumab;Etoposide;Tremelimumab